| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9826 |
| Human Intestinal Absorption | HIA+ | 0.9961 |
| Caco-2 Permeability | Caco2+ | 0.7287 |
| P-glycoprotein Substrate | Non-substrate | 0.7614 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9294 |
| Non-inhibitor | 0.9838 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8367 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4471 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8338 |
| CYP450 2D6 Substrate | Non-substrate | 0.7332 |
| CYP450 3A4 Substrate | Non-substrate | 0.6998 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9249 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7516 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.8548 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7217 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7289 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9493 |
| Non-inhibitor | 0.9351 |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.6958 |
| Fish Toxicity | High FHMT | 0.8276 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9846 |
| Honey Bee Toxicity | Low HBT | 0.6484 |
| Biodegradation | Ready biodegradable | 0.8039 |
| Acute Oral Toxicity | III | 0.6807 |
| Carcinogenicity (Three-class) | Non-required | 0.5475 |